{
    "@context": "https://schema.org",
    "@type": "Article",
    "headline": "The Next in the Series of Executive Orders Affecting the Pharmaceutical Industry",
    "url": "https://www.lexblog.com/2020/09/17/texecutive-orders-pharmaceutical-drug-prices/",
    "identifier": {
        "@type": "PropertyValue",
        "name": "LexBlog Library record",
        "value": "LEX-WK-XDVKBQ3Y",
        "url": "https://www.lexblog.com/lib/XDVKBQ3Y/"
    },
    "datePublished": "2020-09-17T19:31:09-04:00",
    "dateModified": "2020-10-30T08:07:36-04:00",
    "author": {
        "@type": "Person",
        "name": "Dhara Waghela, Melissa Gertler"
    },
    "sourceOrganization": {
        "@type": "Organization",
        "name": "Sheppard, Mullin, Richter & Hampton LLP"
    },
    "organizationScope": "at-publication",
    "isPartOf": "Healthcare Law Blog",
    "about": "Health Care and Life Sciences",
    "sourceUrl": "https://www.sheppardhealthlaw.com/?p=3935",
    "sourceStability": "may-move"
}